Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines

Shirley V Wang1, Abdurrahman Abdurrob1, Julia Spoendlin1

  • 1Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital; Department of Medicine, Harvard Medical School, Boston, MA, USA.

Insights

Investigating childhood immunization safety, this study developed a method to assess risks of vaccines given on the same day. Adjusting for age, it found little evidence of increased seizure risk from DTaP and MMR vaccines administered together.

Area of Science:

  • Immunization Safety
  • Vaccine Epidemiology
  • Pediatric Public Health

Background:

  • Childhood immunization schedules often involve multiple vaccines per visit.
  • Concerns exist regarding the safety of administering vaccines concomitantly (on the same day).
  • Observational studies face methodological challenges in assessing concomitant vaccine safety.

Purpose of the Study:

  • To address methodological challenges in observational studies of concomitant vaccine safety.
  • To develop a process for identifying specific vaccines responsible for adverse events when administered together.
  • To adjust for confounding factors related to vaccine combinations and risk factors.

Main Methods:

  • Utilized a self-controlled design for observational vaccine safety studies.
  • Proposed a method to distinguish individual vaccine contributions to adverse events.
  • Re-examined seizure risk post-measles-mumps-rubella (MMR) vaccination, assessing other vaccine effects.
  • Adjusted for time-invariant effect modifiers like age at vaccination.

Main Results:

  • Initial analyses suggested DTaP had independent and potentiating effects on seizure risk.
  • After adjusting for age and vaccine combinations, minimal evidence supported increased seizure risk with same-day DTaP and MMR administration (IRR 1.2 [0.9-1.6]).

Conclusions:

  • Adjusting for time-invariant effect modifiers, such as age, is crucial in self-controlled designs for concomitant vaccine safety.
  • Age at vaccination is structurally related to vaccination patterns in recommended schedules.
  • The findings highlight the importance of robust statistical methods in vaccine safety research.
Abstract

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.